Efficacy and safety of dapsone as second line therapy for adult immune thrombocytopenia: A retrospective study of 42 patients

Dapsone is recommended as a second line therapy in immune thrombocytopenia (ITP), but is underused because of its potential side effects. The medical charts of 42 ITP patients treated with dapsone (100 mg/day) were retrospectively reviewed in order to assess its efficacy and safety in daily clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Estève, Clémentine, Samson, Maxime, Guilhem, Alexandre, Nicolas, Barbara, Leguy-Seguin, Vanessa, Berthier, Sabine, Bonnotte, Bernard, Audia, Sylvain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662230/
https://www.ncbi.nlm.nih.gov/pubmed/29084292
http://dx.doi.org/10.1371/journal.pone.0187296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662230/
https://www.ncbi.nlm.nih.gov/pubmed/29084292
http://dx.doi.org/10.1371/journal.pone.0187296

Ejemplares similares